3-119708650-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_033364.4(CFAP91):āc.419A>Gā(p.Lys140Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000207 in 1,448,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_033364.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP91 | NM_033364.4 | c.419A>G | p.Lys140Arg | missense_variant | 4/18 | ENST00000273390.9 | NP_203528.3 | |
CFAP91 | NM_001320316.2 | c.359A>G | p.Lys120Arg | missense_variant | 4/18 | NP_001307245.2 | ||
CFAP91 | NM_001320317.2 | c.233A>G | p.Lys78Arg | missense_variant | 3/17 | NP_001307246.2 | ||
CFAP91 | NM_001320318.2 | c.41A>G | p.Lys14Arg | missense_variant | 2/16 | NP_001307247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP91 | ENST00000273390.9 | c.419A>G | p.Lys140Arg | missense_variant | 4/18 | 1 | NM_033364.4 | ENSP00000273390.5 | ||
ENSG00000285585 | ENST00000648112.1 | c.419A>G | p.Lys140Arg | missense_variant | 4/18 | ENSP00000497876.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247488Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 133976
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1448008Hom.: 0 Cov.: 27 AF XY: 0.00000277 AC XY: 2AN XY: 720838
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at